Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionSignaturefd, Llc
Latest Disclosed Ownership583 shares
Latest Disclosed Value $ 76,769
Signaturefd, Llc reports 69.71% decrease in ownership of NBIX / Neurocrine Biosciences, Inc.

On April 7, 2026 - Signaturefd, Llc filed a 13F-HR form disclosing ownership of 583 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $76,769 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 1,925 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -69.71% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 583 -1,342 -69.71 77 -72.16 0.0012
2026-01-20 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,925 83 4.51 273 5.81 0.0042
2025-10-21 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,842 9 0.49 259 12.17 0.0041
2025-07-16 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,833 -607 -24.88 230 -14.50 0.0039
2025-05-02 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,440 -361 -12.89 270 -29.58 0.0051
2025-02-10 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,801 165 6.26 382 26.07 0.0072
2024-10-21 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,636 -88 -3.23 304 -19.20 0.0058
2024-07-29 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,724 162 6.32 375 6.23 0.0076
2024-05-03 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,562 51 2.03 353 6.97 0.0075
2024-02-01 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,511 125 5.24 331 23.13 0.0076
2023-11-03 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,386 1,990 502.53 268 624.32 0.0070
2023-08-01 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 396 -40 -9.17 37 -15.91 0.0010
2023-04-28 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 436 151 52.98 44 29.41 0.0012
2023-01-30 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 285 27 10.47 34 25.93 0.0010
2022-11-08 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 258 -26 -9.15 27 -3.57 0.0009
2022-08-10 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 284 -12 -4.05 28 0.00 0.0010
2022-05-02 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 296 42 16.54 28 27.27 0.0008
2022-01-25 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 254 -431 -62.92 22 -66.67 0.0007
2021-10-28 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 685 -2 -0.29 66 -1.49 0.0023
2021-07-26 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 687 7 1.03 67 1.52 0.0027
2021-04-30 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 680 -14 -2.02 66 -1.49 0.0029
2021-02-11 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 694 -1,048 -60.16 67 -60.12 0.0032
2020-11-03 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,742 106 6.48 168 -16.00 0.0090
2020-07-30 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,636 74 4.74 200 48.15 0.0121
2020-04-23 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,562 132 9.23 135 -12.34 0.0117
2020-02-05 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,430 81 6.00 154 26.23 0.0114
2019-10-16 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,349 0 0.00 122 7.02 0.0100
2019-07-31 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,349 10 0.75 114 -3.39 0.0099
2019-05-09 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,339 0 0.00 118 22.92 0.0100
2019-02-13 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,339 1 0.07 96 -41.82 0.0089
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,338 1,000 295.86 165 400.00 0.0168
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 338 0 0.00 33 17.86 0.0037
2018-05-08 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 338 338 28 0.0033
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -200 -100.00 0 -100.00
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 10 11.11 0.0015
2016-07-29 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 9 12.50 0.0013
2016-05-12 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 8 -27.27 0.0014
2016-01-22 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 11 37.50 0.0021
2015-10-23 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 8 -20.00 0.0018
2015-07-15 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 10 25.00 0.0022
2015-04-15 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 8 100.00 0.0019
2015-02-13 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 4 33.33 0.0010
2014-11-13 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 3 0.00 0.0010
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 3 0.00 0.0010
2014-05-16 2014-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 3 50.00 0.0012
2014-02-11 2013-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 2 0.00 0.0007
2013-11-13 2013-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 0 0.00 2 -33.33 0.0009
2013-08-14 2013-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 200 200 3 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.